Home » Topics » BioWorld Science

BioWorld Science
RSS

Italian trial evaluates siltuximab for COVID-19 patients with serious respiratory complications

March 18, 2020

Grant supports clinical evaluation of Vaxxas' HD-MAP platform for measles and rubella vaccination

March 18, 2020

Organ microbiomes associated with diabetes risk

March 18, 2020

Risk factors for mortality in adult patients with COVID-19

March 18, 2020

Researchers unveil GluN2A targeting as therapeutic strategy for treating SLE-derived neuropathy

March 18, 2020

Mortalin as a new therapeutic target for B-Raf-mutant or MEK/ERK-driven tumors

March 18, 2020

PD-1/PD-L1 interaction inhibitors patented by Shenzhen Chipscreen Biosciences

March 18, 2020

Xenon Pharmaceuticals identifies sodium channel protein type 8 subunit alpha blockers

March 18, 2020

New aryl hydrocarbon receptor antagonists disclosed by JAGUAHR Therapeutics

March 18, 2020

Ultupharma discovers new antibacterials

March 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.